Oak Street Health (OSH) Misses Q2 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day losing streak as stocks reclaim some shine
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Oak Street Health (OSH) PT Lowered to $70 at Cantor Fitzgerald
August 10, 2021 3:49 PM EDTCantor Fitzgerald analyst Steven Halper lowered the price target on Oak Street Health (NYSE: OSH) to $70.00 (from $75.00) while maintaining an Overweight rating.
The analyst commented, "We reiterate our Overweight rating on OSH shares, but lower our price target to $70 from $75. After the market close... More
